logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Therapeutic Fcfusion Proteins 1st Edition Steven M Chamow Thomas Ryll

  • SKU: BELL-4724318
Therapeutic Fcfusion Proteins 1st Edition Steven M Chamow Thomas Ryll
$ 31.00 $ 45.00 (-31%)

5.0

70 reviews

Therapeutic Fcfusion Proteins 1st Edition Steven M Chamow Thomas Ryll instant download after payment.

Publisher: Wiley-Blackwell
File Extension: PDF
File size: 7.36 MB
Pages: 400
Author: Steven M. Chamow, Thomas Ryll, Henry B. Lowman, Deborah Farson
ISBN: 9783527333172, 9783527675272, 3527333177, 3527675272
Language: English
Year: 2014
Edition: 1

Product desciption

Therapeutic Fcfusion Proteins 1st Edition Steven M Chamow Thomas Ryll by Steven M. Chamow, Thomas Ryll, Henry B. Lowman, Deborah Farson 9783527333172, 9783527675272, 3527333177, 3527675272 instant download after payment.

Edited by three pioneers in the field – each with longstanding experience in the biotech industry – and a skilled scientific writer, this is the first book to cover every step in the development and production of immunoglobulin Fc-fusion proteins as therapeutics for human disease: from choosing the right molecular design, to pre-clinical characterization of the purified product, through to batch optimization and quality control for large-scale cGMP production.

The whole of the second part is devoted to case studies of Fc-fusion proteins that are now commercially successful products. In this section, the authors, several of whom were personally involved in clinical development of the products themselves, detail the product’s background and give insight into issues that were faced and how these issues were overcome during clinical development. This section also includes a chapter on promising new developments for the future.

An invaluable resource for professionals already working on Fc-fusion proteins and an excellent and thorough introduction for physicians, researchers, and students entering the field.

Related Products